Our observation of worse prostate cancer outcome following the 2012 USPSTF's recommendation against PSA-based screening is consistent with that of previous studies, which report that the USPSTF’s 2012 PSA screening recommendation has had profound effects on the presentation and management of prostate cancer. Here, KLK3 is linked to prostate carcinoma.